Clinical Trial Update: Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD) [Phase 4]

View source ↗

Summary

This entry reports a Phase 4 add-on trial evaluating delta-9-tetrahydrocannabinol (THC) for posttraumatic stress disorder; the trial status is currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Delta-9-tetrahydrocannabinol (THC) (Delta-9-tetrahydrocannabinol)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Posttraumatic Stress Disorders | Phase 4 | Status: UNKNOWN